International Stem Cell CORP
ISCO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001355790
In the last 90 days, International Stem Cell CORP insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding International Stem Cell CORP changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 20 | 20 | 0 (0.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held International Stem Cell CORP at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (0)
Institutions that held International Stem Cell CORP at the end of Q2 2021 and filed for Q3 2021 without it.
None.